# Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study

> **NCT02027480** · — · COMPLETED · sponsor: **Columbia University** · enrollment: 685 (actual)

## Conditions studied

- HIV (Human Immunodeficiency Virus)
- AIDS (Acquired Immune Deficiency Syndrome)
- Tuberculosis
- Non-communicable Diseases (NCD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02027480
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 685 (ACTUAL)
- **Last updated:** 2015-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02027480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02027480, "Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02027480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*